The Capital Quest | Israel Diagnostic Robotics, Point Compliance Series B Pocket Checks
Israeli medtech startup Diagnostic Robotics has raised $45 million in a Series B funding round led by StageOne Ventures.
Israeli investors Midgal Insurance, Clal Insurance and Bank Hapoalim, as well as Mayo Clinic and the company’s existing investors also joined the round.
Brad Bloom, co-founder of Berkshire Partners, and Gigi Levy-Weiss, co-founder of NFX, also participated.
The 60-person-strong company will use the new funds to hire more staff in functions such as marketing and sales. It will also develop more analytical models to solve clinical problems.
The startup was founded by Kira Redinsky in 2017 along with Yonatan Amir and Moshe Shoham. Redinsky is the startup’s CEO while Amir is the president and Shoham is the engineering director.
Shoham previously founded and sold Mazor Robotics to Medtronic for $1.6 billion in 2018.
Diagnostic Robotics, which developed a platform based on predictive artificial intelligence, has now raised $70 million. He had raised $24 million in a Series A round in 2019 and an undisclosed amount in 2021.
Dot Compliance, an Israeli startup that developed an out-of-the-box security compliance platform, raised $23 million in a Series B funding round.
The round was led by Israel Growth Partners (IGP) and joined by existing investors Vertex Ventures and TPY Capital.
Thanks to this, the startup has now raised $33 million since its inception in 2015. The company employs 80 people, 60 of whom work outside of Israel.
Dot Compliance claims to have more than 200 clients in 15 countries and claims to have recorded triple-digit growth over the past three years.
“Dot Compliance has disrupted a traditionally slow space, setting a new standard for easy-to-deploy QMS solutions,” said Doron Sitbon, Founder and CEO of Dot Compliance. “The additional funds will allow us to advance our efforts to enable life science organizations to rapidly automate their development and manufacturing processes while ensuring compliance.”